Your browser doesn't support javascript.
loading
A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors.
Doi, Toshihiko; Fuse, Nozomu; Yoshino, Takayuki; Kojima, Takashi; Bando, Hideaki; Miyamoto, Hideaki; Kaneko, Masato; Osada, Motonobu; Ohtsu, Atsushi.
Afiliação
  • Doi T; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan. tdoi@east.ncc.go.jp.
  • Fuse N; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Yoshino T; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Kojima T; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Bando H; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
  • Miyamoto H; Department of Gastroenterology and Hepatology, Kumamoto University, 2-39-1 Kurokami, Chuo Ward, Kumamoto, 860-8555, Japan.
  • Kaneko M; Bayer Yakuhin, Ltd., 2-4-9, Umeda, Kita-ku, Osaka, 530-0001, Japan.
  • Osada M; Bayer Yakuhin, Ltd., 2-4-9, Umeda, Kita-ku, Osaka, 530-0001, Japan.
  • Ohtsu A; National Cancer Center Hospital East, 5-1, Kashiwanoha 6-chome, Kashiwa-shi, Chiba, 277-8577, Japan.
Cancer Chemother Pharmacol ; 79(1): 89-98, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27915408

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Quinazolinas / Inibidores de Fosfoinositídeo-3 Quinase / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Quinazolinas / Inibidores de Fosfoinositídeo-3 Quinase / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article